HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 Drug Patent Profile
✉ Email this page to a colleague
When do Hydralazine Hydrochloride W/ Hydrochlorothiazide 25/25 patents expire, and what generic alternatives are available?
Hydralazine Hydrochloride W/ Hydrochlorothiazide 25/25 is a drug marketed by Ivax Pharms and is included in one NDA.
The generic ingredient in HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25?
- What are the global sales for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25?
- What is Average Wholesale Price for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25?
Summary for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 3 |
| DailyMed Link: | HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 at DailyMed |
Recent Clinical Trials for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt University Medical Center | Phase 4 |
| National Center for Research Resources (NCRR) | Phase 4 |
| Vanderbilt University Medical Center | Phase 1 |
See all HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 clinical trials
US Patents and Regulatory Information for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivax Pharms | HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 | hydralazine hydrochloride; hydrochlorothiazide | CAPSULE;ORAL | 088356-001 | Apr 10, 1984 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
